Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound

Maria Assunta Zocco; Matteo Garcovich; Andrea Lupascu; Enrico Di Stasio; Davide Roccarina; Brigida Eleonora Annicchiarico; Laura Riccardi; Maria Elena Ainora; Francesca Romana Ponziani; Gianluigi Caracciolo; Gian Ludovico Rapaccini; Raffaele Landolfi; Massimo Siciliano; Maurizio Pompili; Antonio Gasbarrini

doi:10.1016/j.jhep.2013.06.011

Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound

Maria Assunta Zocco
, Matteo Garcovich
, Andrea Lupascu
, Enrico Di Stasio
, Davide Roccarina
, Brigida Eleonora Annicchiarico
, Laura Riccardi
, Maria Elena Ainora
, Francesca Romana Ponziani
, Gianluigi Caracciolo
, Gian Ludovico Rapaccini
, Raffaele Landolfi
, Massimo Siciliano
, Maurizio Pompili
, Antonio Gasbarrini

Risultato della ricerca: Contributo in rivista › Articolo

55 Citazioni (Scopus)

Abstract

Sorafenib has become the standard first-line treatment for patients with advanced HCC and acts by inducing alterations in tumor vascularity. We wanted to evaluate the feasibility of dynamic CEUS (D-CEUS) as a predictor of early tumor response to sorafenib and to correlate functional parameters with clinical efficacy end points.

Lingua originale	Inglese
pagine (da-a)	1014-1021
Numero di pagine	8
Rivista	Journal of Hepatology
Volume	59
DOI	https://doi.org/10.1016/j.jhep.2013.06.011
Stato di pubblicazione	Pubblicato - 2013

Keywords

Dynamic contrast enhanced ultrasound
Hepatocellular carcinoma
Sorafenib
Tumour response

Accesso al documento

10.1016/j.jhep.2013.06.011

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Zocco, M. A., Garcovich, M., Lupascu, A., Di Stasio, E., Roccarina, D., Annicchiarico, B. E., Riccardi, L., Ainora, M. E., Ponziani, F. R., Caracciolo, G., Rapaccini, G. L., Landolfi, R., Siciliano, M., Pompili, M., & Gasbarrini, A. (2013). Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound. Journal of Hepatology, 59, 1014-1021. https://doi.org/10.1016/j.jhep.2013.06.011

@article{fa2985a67fa3464ca247ecbc078e864b,

title = "Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound",

abstract = "Sorafenib has become the standard first-line treatment for patients with advanced HCC and acts by inducing alterations in tumor vascularity. We wanted to evaluate the feasibility of dynamic CEUS (D-CEUS) as a predictor of early tumor response to sorafenib and to correlate functional parameters with clinical efficacy end points.",

keywords = "Dynamic contrast enhanced ultrasound, Hepatocellular carcinoma, Sorafenib, Tumour response, Dynamic contrast enhanced ultrasound, Hepatocellular carcinoma, Sorafenib, Tumour response",

author = "Zocco, \{Maria Assunta\} and Matteo Garcovich and Andrea Lupascu and \{Di Stasio\}, Enrico and Davide Roccarina and Annicchiarico, \{Brigida Eleonora\} and Laura Riccardi and Ainora, \{Maria Elena\} and Ponziani, \{Francesca Romana\} and Gianluigi Caracciolo and Rapaccini, \{Gian Ludovico\} and Raffaele Landolfi and Massimo Siciliano and Maurizio Pompili and Antonio Gasbarrini",

year = "2013",

doi = "10.1016/j.jhep.2013.06.011",

language = "English",

volume = "59",

pages = "1014--1021",

journal = "Journal of Hepatology",

issn = "0168-8278",

publisher = "Elsevier B.V.",

}

Zocco, MA, Garcovich, M, Lupascu, A, Di Stasio, E, Roccarina, D, Annicchiarico, BE, Riccardi, L, Ainora, ME, Ponziani, FR, Caracciolo, G, Rapaccini, GL, Landolfi, R, Siciliano, M, Pompili, M & Gasbarrini, A 2013, 'Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound', Journal of Hepatology, vol. 59, pagg. 1014-1021. https://doi.org/10.1016/j.jhep.2013.06.011

TY - JOUR

T1 - Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound

AU - Zocco, Maria Assunta

AU - Garcovich, Matteo

AU - Lupascu, Andrea

AU - Di Stasio, Enrico

AU - Roccarina, Davide

AU - Annicchiarico, Brigida Eleonora

AU - Riccardi, Laura

AU - Ainora, Maria Elena

AU - Ponziani, Francesca Romana

AU - Caracciolo, Gianluigi

AU - Rapaccini, Gian Ludovico

AU - Landolfi, Raffaele

AU - Siciliano, Massimo

AU - Pompili, Maurizio

AU - Gasbarrini, Antonio

PY - 2013

Y1 - 2013

N2 - Sorafenib has become the standard first-line treatment for patients with advanced HCC and acts by inducing alterations in tumor vascularity. We wanted to evaluate the feasibility of dynamic CEUS (D-CEUS) as a predictor of early tumor response to sorafenib and to correlate functional parameters with clinical efficacy end points.

AB - Sorafenib has become the standard first-line treatment for patients with advanced HCC and acts by inducing alterations in tumor vascularity. We wanted to evaluate the feasibility of dynamic CEUS (D-CEUS) as a predictor of early tumor response to sorafenib and to correlate functional parameters with clinical efficacy end points.

KW - Dynamic contrast enhanced ultrasound

KW - Hepatocellular carcinoma

KW - Sorafenib

KW - Tumour response

KW - Dynamic contrast enhanced ultrasound

KW - Hepatocellular carcinoma

KW - Sorafenib

KW - Tumour response

UR - http://hdl.handle.net/10807/52141

U2 - 10.1016/j.jhep.2013.06.011

DO - 10.1016/j.jhep.2013.06.011

M3 - Article

SN - 0168-8278

VL - 59

SP - 1014

EP - 1021

JO - Journal of Hepatology

JF - Journal of Hepatology

ER -

Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo